Therapeutic agents for reducing parathyroid hormone levels

Details for Australian Patent Application No. 2010278897 (hide)

Owner KAI Pharmaceuticals, Inc.

Inventors Karim, Felix; Baruch, Amos; Maclean, Derek; Das, Kanad; Yin, Qun

Agent FB Rice

Pub. Number AU-A-2010278897

PCT Pub. Number WO2011/014707

Priority 61/255,816 28.10.09 US; 61/229,695 29.07.09 US; 61/313,635 12.03.10 US

Filing date 29 July 2010

Wipo publication date 3 February 2011

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 5/20 (2006.01) Drugs for disorders of the endocrine system

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014707 Priority application(s): WO2011/014707

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010278900-Systems and methods to provide benefits according to account features

2010278894-Infusion pump system with disposable cartridge having pressure venting and pressure feedback